Primary breast lymphoma: A rare case report.
| Autor: | Alkerata A; AL Andalus Private University for Medical Sciences, Faculty of Medicine, Syria. Electronic address: ak92@au.edu.sy., Al-Janabi MH; Department of Pathology, Cancer Research Center, Tishreen University Hospital, Lattakia, Syria. Electronic address: dr.3esami2022@gmail.com., Ahmad YI; Faculty of Medicine, Tishreen University, Lattakia, Syria., Jbeili SS; Department of General Surgery, Tishreen University Hospital, Lattakia, Syria., Ahmad IY; Tishreen University and AL Andalus Private University for Medical Sciences, Faculty of Medicine, Department of Pathology, Tishreen University Hospital, Syria. Electronic address: ai02@au.edu.sy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of surgery case reports [Int J Surg Case Rep] 2024 Sep; Vol. 122, pp. 110120. Date of Electronic Publication: 2024 Aug 03. |
| DOI: | 10.1016/j.ijscr.2024.110120 |
| Abstrakt: | Introduction and Importance: Primary breast lymphoma (PBL) is an extremely rare neoplasm, accounting for less than 1 % of breast malignancies and less than 2 % of extranodal non-Hodgkin lymphomas (NHLs). Case Presentation: This case report discusses a 60-year-old female patient presenting with a primary breast lymphoma, specifically diffuse large B-cell lymphoma. The patient had no personal history of breast cancer but exhibited a painless, palpable mass in the left breast with axillary lymphadenopathy. Clinical Discussion: Diagnostic challenges in distinguishing PBL from primary breast carcinoma are addressed, emphasizing the importance of considering PBL in cases of rapidly enlarging breast masses. Radiological examinations, including mammography and ultrasound, play a crucial role in diagnosis, and excisional biopsy with immunohistochemical staining is essential for accurate histopathological subcategorization. Conclusion: The presented case underscores the rarity of PBL in the Middle East and highlights the diagnostic and classification challenges, emphasizing the central role of accurate techniques in guiding treatment decisions. Competing Interests: Conflict of interest statement The authors have no conflicts of interest to declare. (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|